Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection

The Medical and Surgical Practice of NaProTECHNOLOGY, 413-424

Source

Abstract

No abstract available for this article.

Topics

abnormal bleeding PCOS endometrial cancer risk, breast cancer progesterone deficiency prevention, cervical mucus observation cancer early detection, cycle charting endometrial hyperplasia screening, dysfunctional uterine bleeding cancer screening, early detection endometrial cancer through charting, irregular cycles endometrial cancer prophylaxis, luteal phase deficiency breast cancer correlation, mucus cycle score breast cancer risk marker, NaProTECHNOLOGY cancer prevention protocols, ovarian cancer large follicle structural abnormality, PCOS unopposed estrogen endometrial cancer, post-peak progesterone breast cancer screening, postmenopausal bleeding chart observation cancer, premenopausal breast cancer progesterone link, premenstrual spotting breast cancer biomarker, progesterone prophylaxis endometrial cancer prevention, variable post-peak phase breast cancer precursor, body literacy cancer symptom awareness, charting irregular bleeding adenocarcinoma detection, ductal carcinoma in situ progesterone levels, fertility awareness cancer early warning signs, hormone profiles before breast cancer diagnosis, long cycle endometrial hyperplasia treatment, observing vaginal discharge cancer detection, oral contraceptive breast cancer risk comparison, ovulation abnormalities ovarian cancer relationship, patient self-monitoring endometrial cancer symptoms, Peak plus 7 progesterone cancer screening, women at risk endometrial biopsy timing

Cite this article

Hilgers, T. W. (2004). Chapter 34: Cancer: NaProTECHNOLOGY and Early Detection. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 413-424.

Related articles